Literature DB >> 15563914

Future directions in chemosensory research.

Bradley J Goldstein1, Andrew P Lane.   

Abstract

The past two decades have witnessed phenomenal growth in chemosensory research in the basic sciences and clinical studies. Although chemosensory disorders today are recognized more widely for their marked impacts on QOL and public safety, the increased research focus has yet to translate into significant therapeutic advances for human olfactory or gustatory dysfunction. Nevertheless, it should be expected that active chemosensory research eventually will yield discoveries necessary to generate better treatment options for otolaryngologists and other physicians caring for smell and taste loss patients. As the understanding of chemosensory biology and disease pathophysiology grows, there is great promise that medical science will conquer the frustrating and debilitating health problems posed by olfactory and gustatory dysfunction. Moreover, it is likely that the lessons gained through chemosensory research will apply broadly to a range of human diseases affecting sensory modalities and the central nervous system.

Entities:  

Mesh:

Year:  2004        PMID: 15563914     DOI: 10.1016/j.otc.2004.06.004

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

1.  Differentiation potential of individual olfactory c-Kit+ progenitors determined via multicolor lineage tracing.

Authors:  Garrett M Goss; Nirupa Chaudhari; Joshua M Hare; Raphael Nwojo; Barbara Seidler; Dieter Saur; Bradley J Goldstein
Journal:  Dev Neurobiol       Date:  2015-06-10       Impact factor: 3.964

2.  Defects in the peripheral taste structure and function in the MRL/lpr mouse model of autoimmune disease.

Authors:  Agnes Kim; Pu Feng; Tadahiro Ohkuri; Daniel Sauers; Zachary J Cohn; Jinghua Chai; Theodore Nelson; Alexander A Bachmanov; Liquan Huang; Hong Wang
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

3.  Regenerative strategies for craniofacial disorders.

Authors:  Catharine B Garland; Jason H Pomerantz
Journal:  Front Physiol       Date:  2012-12-14       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.